Search

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.

Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to mitigate modifiable risk.

Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.

A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.

A visionary program investigates how the body’s ecosystem affects cancer.

Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.

Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.